Transcranial electrostimulation
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Transcranial electrostimulation, or mesodiencephalic modulation, allows to normalize the work of neuroendocrine centers, disturbed in persons who are dependent on surfactants. During the procedure, a significant change in the electrical and biochemical activity of the centers of the opioid and hypothalamic-pituitary systems located in the middle and oblong brain is noted.
What is transcranial electrostimulation done for?
Restoration of the metabolism of endorphins and monoamines in narcological patients.
Indications
Transcranial electrostimulation is used in the following cases:
- Heavy-current conditions for the abolition of surfactants.
- Resistance and intolerance to the therapy.
- Affective disorders of the depressive and anxious circle in the post-abstinence period.
- Intercurrent somatic and neurological diseases.
Method of conducting
A pair of frontal-occipital electrodes is fed with a constant and alternating electric current of 3-5 mA.
Efficacy of transcranial electrostimulation
Against the background of therapy with mesodysncephalic modulation, which is carried out every day for 10 days, the concentration of somatotropic hormone and insulin increases, rapid restoration of normal functions of opioid and immune systems is observed, and the differences in the basic level of parameters between the main and control groups are statistically significant already on the 3rd day after the onset treatment.
One of the most important effects of transcranial electrostimulation is the potentiation of the effect of most known pharmacological drugs. Thus, the use of mesodysncephalic modulation in the case of a heavy-duty opioid withdrawal syndrome has virtually eliminated the use of the narcotic analgesic - tramadol. The drug was used only twice: on the 1st and 4th days, i.e. At the beginning of treatment and at the height of the withdrawal syndrome.
The use of transcranial electrostimulation in the complex treatment of patients with alcohol dependence in the postabstinent state made it possible to achieve pronounced anti-anxiety, and then, on the 3rd or 4th day of daily use, persistent antidepressant and general stimulating effects.
[